Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$216,900
New position
Shares Held
1,384
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,283
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Facet Wealth, Inc. holds $13,513,916 across 10 Drug Manufacturers - General names. NVS ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,243 | $3,889,751 | |
| 2 | ABBV |
AbbVie Inc.
|
11,184 | $2,814,341 | |
| 3 | JNJ |
Johnson & Johnson
|
10,604 | $2,693,097 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,129 | $1,558,576 | |
| 5 | AMGN |
Amgen Inc
|
2,188 | $792,318 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,331 | $480,032 | |
| 7 | PFE |
Pfizer Inc
|
16,866 | $406,133 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,804 | $354,257 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $216,900 | 1,384 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||